FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nathalie Perez-Staub

Research Profile

Chemicals & Drugs

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Concepts & Ideas

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Arie Figer; Nathalie Perez-Staub; Elisabeth Carola; Christophe Tournigand; Gerard Lledo; Michel Flesch; Ramon Barcelo; Andre Cervantes; Thierry André; Philippe Colin; Christophe Louvet; Aimery de Gramont
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
Aimery de Gramont; Marc Buyse; Jose Cortinas Abrahantes; Tomasz Burzykowski; Emmanuel Quinaux; Andrés Cervantes; Arie Figer; Gérard Lledo; Michel Flesch; Laurent Mineur; Elisabeth Carola; Pierre-Luc Etienne; Fernando Rivera; Isabel Chirivella; Nathalie Perez-Staub; Christophe Louvet; Thierry André; Isabelle Tabah-Fisch; Christophe Tournigand
Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer.
Christophe Tournigand; Andrés Cervantes; Arie Figer; Gérard Lledo; Michel Flesch; Marc Buyse; Laurent Mineur; Elisabeth Carola; Pierre-Luc Etienne; Fernando Rivera; Isabel Chirivella; Nathalie Perez-Staub; Christophe Louvet; Thierry André; Isabelle Tabah-Fisch; Aimery de Gramont
OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nathalie Perez-Staub (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Arie Figer; Nathalie Perez-Staub; Elisabeth Carola; Christophe Tournigand; Gerard Lledo; Michel Flesch; Ramon Barcelo; Andre Cervantes; Thierry André; Philippe Colin; Christophe Louvet; Aimery de Gramont
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
Cancer 2007;110(12):2666-71.
2007: Aimery de Gramont; Marc Buyse; Jose Cortinas Abrahantes; Tomasz Burzykowski; Emmanuel Quinaux; Andrés Cervantes; Arie Figer; Gérard Lledo; Michel Flesch; Laurent Mineur; Elisabeth Carola; Pierre-Luc Etienne; Fernando Rivera; Isabel Chirivella; Nathalie Perez-Staub; Christophe Louvet; Thierry André; Isabelle Tabah-Fisch; Christophe Tournigand
Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3224-9.
2006: Christophe Tournigand; Andrés Cervantes; Arie Figer; Gérard Lledo; Michel Flesch; Marc Buyse; Laurent Mineur; Elisabeth Carola; Pierre-Luc Etienne; Fernando Rivera; Isabel Chirivella; Nathalie Perez-Staub; Christophe Louvet; Thierry André; Isabelle Tabah-Fisch; Aimery de Gramont
OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):394-400.
2005: Frédérique Maindrault-Goebel; Thierry André; Christophe Tournigand; Christophe Louvet; Nathalie Perez-Staub; Nora Zeghib; Aimery de Gramont
Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients.
European journal of cancer (Oxford, England : 1990) 2005;41(15):2262-7.